VA Frailty Index Associated With Survival in AML Patients

Acute myeloid leukemia (AML) is a particularly aggressive blood cancer that is most successfully treated with intensive chemotherapy. As the average age at diagnosis is 68, patients diagnosed with the disease are often too frail to withstand potentially curative treatment with induction regimens.

New Tool Estimates Age-Specific Prostate Cancer Risk

A multi-ancestry polygenic risk score (PRS) that stratifies prostate cancer risk across populations has been developed. In a recent study, the developers validated the performance of the PRS in the multi-ancestry Million Veteran Program and additional independent studies.